Donald Trump threatened pharmaceutical companies. Demanded a reduction in medicine prices


A spokeswoman for the White House, Karoline Leavitt, informed about letting letters during the briefing. She presented a fragment of one of the messages – addressed to the president of the group Eli Lilly – in which Trump explicitly expects the company to commit significant price cuts.
Read also: Kim Jong Un tightens control in Russia. Sends special agents
– In the United States, the prices of branded drugs are today on average even three times higher than in other developed countries. This is a burden that cannot continue to fall on the shoulders of American families Trump said in a letter. – My administration intends to put an end to this. I expect producers that they will provide Americans with immediate relief from inflated prices and stop allowing other countries to benefit from our innovativenessAnd – he added.
Drug prices in the USA in the crosshairs. Trump threatens pharmaceutical concerns
Trump demands that the corporations adapt the prices of drugs on the American market to the lowest levels used in developed countries, such as Germany, Canada or Great Britain. If the company does not submit binding declarations within 60 days, the former president announces the use of all available administrative tools to force changes.
Read also: “Strategic” investor from China in the Polish terminal game. The deputy minister took the floor
– Although we count on cooperation, we will not hesitate to take action if necessary Trump said.
Americans pay more for medicines. Here's what Donald Trump thinks
This is not the first time Trump raises the topic of medicine prices. He had already accused the rule of European countries of imposing low prices to public healthcare systems, which – in his opinion – results in the fact that companies reflect losses, raising prices in the USA. – American patients de facto subsidize health care systems in Europe He claimed many times.
In turn, the pharmaceutical industry defends itself, arguing that higher prices in the US are necessary to cover the costs of research and development of new drugs. This argument, however, does not convince Trump, who considers the current model unfair and harmful to American families.




